Erratum: Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

被引：0
|
作者：
R Atreya
J Mudter
S Finotto
J Müllberg
T Jostock
S Wirtz
M Schütz
B Bartsch
M Holtmann
C Becker
D Strand
J Czaja
J F Schlaak
H A Lehr
F Autschbach
G Schürmann
N Nishimoto
K Yoshizaki
H Ito
T Kishimoto
P R Galle
S Rose-John
M F Neurath
机构：
来源：
Nature Medicine | 2010年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nat. Med. 6, 583–588 (2000); corrected after print 4 November 2010 In the version of this article initially published, the fourth image in Figure 4b was a duplication of the third image. The error has been corrected in the HTML and PDF versions of the article.
引用
收藏
页码：1341 / 1341
相关论文
共 10 条
  • [1] Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
    Atreya, R
    Mudter, J
    Finotto, S
    Müllberg, J
    Jostock, T
    Wirtz, S
    Schütz, M
    Bartsch, B
    Holtmann, M
    Becker, C
    Strand, D
    Czaja, J
    Schlaak, JF
    Lehr, HA
    Autschbach, F
    Schürmann, G
    Nishimoto, N
    Yoshizaki, K
    Ito, H
    Kishimoto, T
    Galle, PR
    Rose-John, S
    Neurath, MF
    NATURE MEDICINE, 2000, 6 (05) : 583 - 588
  • [2] Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
    R. Atreya
    J. Mudter
    S. Finotto
    J. Müllberg
    T. Jostock
    S. Wirtz
    M. Schütz
    B. Bartsch
    M. Holtmann
    C. Becker
    D. Strand
    J. Czaja
    J. F. Schlaak
    H.A. Lehr
    F. Autschbach
    G. Schürmann
    N. Nishimoto
    K. Yoshizaki
    H. Ito
    T. Kishimoto
    P.R. Galle
    S. Rose-John
    M.F. Neurath
    Nature Medicine, 2000, 6 : 583 - 588
  • [3] Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo (vol 6, pg 583, 2000)
    Atreya, R.
    Mudter, J.
    Finotto, S.
    Muellberg, J.
    Jostock, T.
    Wirtz, S.
    Schuetz, M.
    Bartsch, B.
    Holtmann, M.
    Becker, C.
    Strand, D.
    Czaja, J.
    Schlaak, J. F.
    Lehr, H. A.
    Autschbach, F.
    Schuermann, G.
    Nishimoto, N.
    Yoshizaki, K.
    Ito, H.
    Kishimoto, T.
    Galle, P. R.
    Rose-John, S.
    Neurath, M. F.
    NATURE MEDICINE, 2010, 16 (11) : 1341 - 1341
  • [4] Blockade of IL-6 transsignalling abrogates established experimental colitis in mice by suppression of T cell resistance against apoptosis
    Atreya, R
    Mudter, J
    Finotto, S
    Mülberg, J
    Jostock, T
    Schütz, M
    Galle, PR
    Rose-John, S
    Neurath, MF
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S29 - S29
  • [5] Blockade of IL-6 transsignaling abrogates established experimental colitis in mice by suppression of T cell resistance against apoptosis.
    Atreya, R
    Finotto, S
    Mudter, J
    Mullberg, J
    Jostock, T
    Holtmann, M
    Kishimoto, T
    Galle, PR
    Rose-John, S
    Neurath, MF
    GASTROENTEROLOGY, 2000, 118 (04) : A863 - A863
  • [6] TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway
    Chyuan, I. T.
    Tsai, H. F.
    Wu, C. S.
    Hsu, P. N.
    MUCOSAL IMMUNOLOGY, 2019, 12 (04) : 980 - 989
  • [7] T-cell induction of chronic small and large intestinal inflammation in T-cell receptor (TCR) β x δ double deficient mice:: a novel model of Crohn's Disease
    Ostanin, DV
    Laroux, SF
    Pavlick, KP
    Bharwani, S
    Grisham, MB
    FASEB JOURNAL, 2004, 18 (05): : A1266 - A1266
  • [8] Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease
    Chen, Xiao
    Das, Rupali
    Komorowski, Richard
    Beres, Amy
    Hessner, Martin J.
    Mihara, Masahiko
    Drobyski, William R.
    BLOOD, 2009, 114 (04) : 891 - 900
  • [9] An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo
    Stallmach, A
    Marth, T
    Weiss, B
    Wittig, BM
    Hombach, A
    Schmidt, C
    Neurath, M
    Zeitz, M
    Zeuzem, S
    Abken, H
    GUT, 2004, 53 (03) : 339 - 345
  • [10] Galectin-2, a potent modulator of T cell apoptosis, profoundly downregulates intestinal inflammation and improves disease activity in an experimental model of murine colitis
    Sturm, A
    Paclik, D
    Wiedenmann, B
    Gabius, HJ
    Dignass, AU
    INFLAMMATORY BOWEL DISEASES, 2006, 12 : S28 - S28
1